M A Blazing

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy
    M A Blazing
    Duke University Medical Center and Duke University Clinical Research Institute, Durham, NC 27710, USA
    Am Heart J 142:211-7. 2001

Collaborators

Detail Information

Publications1

  1. ncbi request reprint The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy
    M A Blazing
    Duke University Medical Center and Duke University Clinical Research Institute, Durham, NC 27710, USA
    Am Heart J 142:211-7. 2001
    ..The second issue is whether early use of an aggressively dosed statin is superior to a current trial-based "accepted care" regimen of a lower-dose statin started 3 to 6 months after an acute event...